Illinois residents William R. and Diana Greenlee filed a lawsuit in Madison County Circuit Court against Eli Lilly and Co., Takeda Pharmaceuticals America Inc., Takeda Pharmaceutical Company Limited, and Takeda Pharmaceuticals North America Inc., alleging that taking the type 2 diabetes drug Actos caused William to develop bladder cancer.
According to the lawsuit, Greenlee began taking Actos in 2007 and continued to take it daily until September 2011 for long-term maintenance of his high blood sugar. Greenlee learned about the side effects of Actos late into his treatment, including the increased risk of developing bladder cancer. In June 2010, he was diagnosed with the disease.
In the lawsuit, Greenlee says that studies have shown that taking Actos for more than 12 months was linked to an increased risk of bladder cancer; however, the defendants and researchers never published those studies. Greenlee accuses Takeda and Eli Lilly of intentionally withholding that information so the FDA didn’t reject the drug.
In the lawsuit, Greenlee accuses Eli Lilly and Takeda of negligence, negligent failure to warn, and hiding information regarding the risks of the drug Actos. He also alleges strict liability, breach of express warranty and Illinois Consumer Protection law violations.
The lawsuit seeks over $50,000 in actual damages, as well as punitive damages for pain and suffering, economic loss, loss of consortium, and court costs. The lawsuit also requests a jury trial.